• $23.2M
    Market Cap
  • -29.41%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

N/A
No data found

No data found

Momentum Score

Score: 40
Valuation
KAYS
vs History
vs S&P 500
3-Month Momentum
-7.89%
12-Month Momentum
4.47%
3-Month Risk Adjusted Momentum
-12.94%
12-Month Risk Adjusted Momentum
1.82%

True Yield

N/A
No data found

No data found

Financial Health Score

N/A
No data found

No data found